Manufacturer or GPO Program year 2022 Source: CMS Open Payments

Ferring Pharmaceuticals Private Ltd

India

CMS manufacturer 100000136419

Open in the dashboard

General payments

$64,489

50 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2022, Ferring Pharmaceuticals Private Ltd reported paying $64,489 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2022 General $34,516 20
2021 General $8,600 3
2020 General $21,373 27

Breakdown

Top recipients General payments · program year 2022
  1. Fady Sharara Reproductive Endocrinology · Reston, VA $34,516 20 payments
Products the payments named General payments · program year 2022
  1. Menopur Reproductive Health $29,356 100% · 1 recipient

Each share is of this company’s general payments naming a product in 2022. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2022
  1. Reproductive Endocrinology Obstetrics & Gynecology $34,516 100% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. Virginia $34,516 100% · 1 recipient

Each share is of this company’s general payments in 2022 where a state was reported.

What the payments were for General payments · program years 2020–2022
  1. Consulting Fee $29,976 5 payments
  2. Travel and Lodging $19,288 37 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,000 1 payment
  4. Food and Beverage $225 7 payments
Companies with a similar name General payments · program years 2020–2022
  1. Ferring Pharmaceuticals Inc. NJ, United States $12,169,396
  2. Ferring Pharmaceuticals AS Denmark $509,670
  3. Ferring International Pharmascience Center US NJ, United States $371,012
  4. Ferring Holding Inc. NJ, United States $365,851
  5. Ferring International Center SA Switzerland $292,643
  6. Ferring Research Institute Inc. CA, United States $60,580
  7. Ferring Microbiome Inc. MN, United States $51,415
  8. Ferring Pharmaceuticals SA Rep Office Middle East Jordan $50,269
  9. Ferring SA de CV Mexico $33,121
  10. Ferring Pharmaceuticals Pty Ltd Australia $31,075

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 23.

50 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record